Peer-influenced content. Sources you trust. No registration required. This is HCN.
Annals of Internal Medicine
In a recent study assessing chronic insomnia treatments in hemodialysis patients, no significant difference was observed between CBT-I, trazodone, and placebo in improving Insomnia Severity Index scores. This highlights a critical need for alternative therapeutic approaches in this unique patient population.
Nephrology January 24th 2024
Cleveland Clinic Journal of Medicine
Recent studies reveal that adding ezetimibe to lower-intensity statin therapy is as effective as high-intensity statin therapy alone in preventing major cardiovascular events, offering a new approach to lipid management in patients intolerant to high-intensity statins.
Cardiology January 18th 2024
ACP Internist
In the delicate dance of AI and healthcare, a sobering revelation surfaces—predictive models, designed to enhance accuracy in ICU predictions, may inadvertently compromise their own efficacy.
Internal Medicine November 28th 2023
The New England Journal of Medicine
A recent case of a 38-year-old man with end-stage renal disease highlighted the rare but significant complication of quadriceps tendon rupture, often associated with chronic kidney disease and secondary hyperparathyroidism.
Emergency Medicine November 15th 2023
Fox Chase Cancer Center
A recent study from Fox Chase Cancer Center has revealed that as many as 23% of cystic renal masses may carry high-grade, or aggressive, disease. This finding challenges the prevailing assumption of their low-risk nature and underscores the need for more discerning diagnostic and treatment strategies.
Oncology, Medical November 6th 2023
Medical Professionals Reference (MPR)
The approval of empagliflozin opens up a new avenue in CKD treatment. With its proven efficacy in reducing the risk of disease progression by 28%, it offers a promising alternative for healthcare professionals dealing with this prevalent condition.
Endocrinology, Diabetes, Metabolism October 30th 2023